Clinical outcomes of rhabdomyosarcoma and Ewing's sarcoma of the head and neck in children

Paolo Gradoni, Davide Giordano, Gabriele Oretti, Mauro Fantoni, Angelica Barone, Silvia La Cava, Andrea Ferri, Enrico Sesenna, Teore Ferri, Gian Carlo Izzi

Research output: Contribution to journalArticle

Abstract

Objective: To review our experience and critically evaluate treatment strategy and results in children with head and neck rhabdomyosarcoma and Ewing's sarcoma. Methods: Retrospective charts review of children affected by non-orbital rhabdomyosarcoma or Ewing's sarcoma of the head and neck who were treated at our institution from January 1996 to August 2009. Results: Seven consecutive children with head and neck rhabdomyosarcoma or Ewing's sarcoma were identified. Four children had rhabdomyosarcoma, 3 children had Ewing's sarcoma. Regions involved were: cheek, ethmoid and maxillary sinuses, nasopharynx, middle ear/mastoid and frontal bone. In one case, surgery was performed as primary treatment modality; the other children were treated firstly with chemotherapy. Three patients underwent surgical resection after chemotherapy, while 4 patients received radiotherapy. Five children are disease free after a median of 7.7 years from initial diagnosis. Two patients relapsed after 10 and 29 months from initial diagnosis respectively; despite the administration of additional therapy both children died of disease. Conclusion: Treatment for rhabdomyosarcoma and Ewing's sarcoma consists in a multimodal therapy involving chemotherapy, radiotherapy and surgery. The optimum use, timing and intensity of these three treatments are still matters of international debate. Chemotherapy in association with radiotherapy has proven capable to obtain local and distant control of disease. But when surgery is unfeasible or fails in radicality, local control is difficult without radiotherapy. Despite additional therapeutic efforts, prognosis of relapsing disease remains poor.

Original languageEnglish
Pages (from-to)480-486
Number of pages7
JournalAuris Nasus Larynx
Volume38
Issue number4
DOIs
Publication statusPublished - Aug 2011

Fingerprint

Ewing's Sarcoma
Rhabdomyosarcoma
Neck
Head
Radiotherapy
Drug Therapy
Therapeutics
Ethmoid Sinus
Frontal Bone
Mastoid
Nasopharynx
Maxillary Sinus
Cheek
Middle Ear

Keywords

  • Children
  • Ewing's sarcoma
  • Head and neck
  • Rhabdomyosarcoma

ASJC Scopus subject areas

  • Otorhinolaryngology
  • Surgery

Cite this

Clinical outcomes of rhabdomyosarcoma and Ewing's sarcoma of the head and neck in children. / Gradoni, Paolo; Giordano, Davide; Oretti, Gabriele; Fantoni, Mauro; Barone, Angelica; La Cava, Silvia; Ferri, Andrea; Sesenna, Enrico; Ferri, Teore; Izzi, Gian Carlo.

In: Auris Nasus Larynx, Vol. 38, No. 4, 08.2011, p. 480-486.

Research output: Contribution to journalArticle

Gradoni, P, Giordano, D, Oretti, G, Fantoni, M, Barone, A, La Cava, S, Ferri, A, Sesenna, E, Ferri, T & Izzi, GC 2011, 'Clinical outcomes of rhabdomyosarcoma and Ewing's sarcoma of the head and neck in children', Auris Nasus Larynx, vol. 38, no. 4, pp. 480-486. https://doi.org/10.1016/j.anl.2010.12.004
Gradoni, Paolo ; Giordano, Davide ; Oretti, Gabriele ; Fantoni, Mauro ; Barone, Angelica ; La Cava, Silvia ; Ferri, Andrea ; Sesenna, Enrico ; Ferri, Teore ; Izzi, Gian Carlo. / Clinical outcomes of rhabdomyosarcoma and Ewing's sarcoma of the head and neck in children. In: Auris Nasus Larynx. 2011 ; Vol. 38, No. 4. pp. 480-486.
@article{646e4c75771d48759e1b1597a44d4bd6,
title = "Clinical outcomes of rhabdomyosarcoma and Ewing's sarcoma of the head and neck in children",
abstract = "Objective: To review our experience and critically evaluate treatment strategy and results in children with head and neck rhabdomyosarcoma and Ewing's sarcoma. Methods: Retrospective charts review of children affected by non-orbital rhabdomyosarcoma or Ewing's sarcoma of the head and neck who were treated at our institution from January 1996 to August 2009. Results: Seven consecutive children with head and neck rhabdomyosarcoma or Ewing's sarcoma were identified. Four children had rhabdomyosarcoma, 3 children had Ewing's sarcoma. Regions involved were: cheek, ethmoid and maxillary sinuses, nasopharynx, middle ear/mastoid and frontal bone. In one case, surgery was performed as primary treatment modality; the other children were treated firstly with chemotherapy. Three patients underwent surgical resection after chemotherapy, while 4 patients received radiotherapy. Five children are disease free after a median of 7.7 years from initial diagnosis. Two patients relapsed after 10 and 29 months from initial diagnosis respectively; despite the administration of additional therapy both children died of disease. Conclusion: Treatment for rhabdomyosarcoma and Ewing's sarcoma consists in a multimodal therapy involving chemotherapy, radiotherapy and surgery. The optimum use, timing and intensity of these three treatments are still matters of international debate. Chemotherapy in association with radiotherapy has proven capable to obtain local and distant control of disease. But when surgery is unfeasible or fails in radicality, local control is difficult without radiotherapy. Despite additional therapeutic efforts, prognosis of relapsing disease remains poor.",
keywords = "Children, Ewing's sarcoma, Head and neck, Rhabdomyosarcoma",
author = "Paolo Gradoni and Davide Giordano and Gabriele Oretti and Mauro Fantoni and Angelica Barone and {La Cava}, Silvia and Andrea Ferri and Enrico Sesenna and Teore Ferri and Izzi, {Gian Carlo}",
year = "2011",
month = "8",
doi = "10.1016/j.anl.2010.12.004",
language = "English",
volume = "38",
pages = "480--486",
journal = "Auris Nasus Larynx",
issn = "0385-8146",
publisher = "Elsevier Ireland Ltd",
number = "4",

}

TY - JOUR

T1 - Clinical outcomes of rhabdomyosarcoma and Ewing's sarcoma of the head and neck in children

AU - Gradoni, Paolo

AU - Giordano, Davide

AU - Oretti, Gabriele

AU - Fantoni, Mauro

AU - Barone, Angelica

AU - La Cava, Silvia

AU - Ferri, Andrea

AU - Sesenna, Enrico

AU - Ferri, Teore

AU - Izzi, Gian Carlo

PY - 2011/8

Y1 - 2011/8

N2 - Objective: To review our experience and critically evaluate treatment strategy and results in children with head and neck rhabdomyosarcoma and Ewing's sarcoma. Methods: Retrospective charts review of children affected by non-orbital rhabdomyosarcoma or Ewing's sarcoma of the head and neck who were treated at our institution from January 1996 to August 2009. Results: Seven consecutive children with head and neck rhabdomyosarcoma or Ewing's sarcoma were identified. Four children had rhabdomyosarcoma, 3 children had Ewing's sarcoma. Regions involved were: cheek, ethmoid and maxillary sinuses, nasopharynx, middle ear/mastoid and frontal bone. In one case, surgery was performed as primary treatment modality; the other children were treated firstly with chemotherapy. Three patients underwent surgical resection after chemotherapy, while 4 patients received radiotherapy. Five children are disease free after a median of 7.7 years from initial diagnosis. Two patients relapsed after 10 and 29 months from initial diagnosis respectively; despite the administration of additional therapy both children died of disease. Conclusion: Treatment for rhabdomyosarcoma and Ewing's sarcoma consists in a multimodal therapy involving chemotherapy, radiotherapy and surgery. The optimum use, timing and intensity of these three treatments are still matters of international debate. Chemotherapy in association with radiotherapy has proven capable to obtain local and distant control of disease. But when surgery is unfeasible or fails in radicality, local control is difficult without radiotherapy. Despite additional therapeutic efforts, prognosis of relapsing disease remains poor.

AB - Objective: To review our experience and critically evaluate treatment strategy and results in children with head and neck rhabdomyosarcoma and Ewing's sarcoma. Methods: Retrospective charts review of children affected by non-orbital rhabdomyosarcoma or Ewing's sarcoma of the head and neck who were treated at our institution from January 1996 to August 2009. Results: Seven consecutive children with head and neck rhabdomyosarcoma or Ewing's sarcoma were identified. Four children had rhabdomyosarcoma, 3 children had Ewing's sarcoma. Regions involved were: cheek, ethmoid and maxillary sinuses, nasopharynx, middle ear/mastoid and frontal bone. In one case, surgery was performed as primary treatment modality; the other children were treated firstly with chemotherapy. Three patients underwent surgical resection after chemotherapy, while 4 patients received radiotherapy. Five children are disease free after a median of 7.7 years from initial diagnosis. Two patients relapsed after 10 and 29 months from initial diagnosis respectively; despite the administration of additional therapy both children died of disease. Conclusion: Treatment for rhabdomyosarcoma and Ewing's sarcoma consists in a multimodal therapy involving chemotherapy, radiotherapy and surgery. The optimum use, timing and intensity of these three treatments are still matters of international debate. Chemotherapy in association with radiotherapy has proven capable to obtain local and distant control of disease. But when surgery is unfeasible or fails in radicality, local control is difficult without radiotherapy. Despite additional therapeutic efforts, prognosis of relapsing disease remains poor.

KW - Children

KW - Ewing's sarcoma

KW - Head and neck

KW - Rhabdomyosarcoma

UR - http://www.scopus.com/inward/record.url?scp=79953056594&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79953056594&partnerID=8YFLogxK

U2 - 10.1016/j.anl.2010.12.004

DO - 10.1016/j.anl.2010.12.004

M3 - Article

C2 - 21227608

AN - SCOPUS:79953056594

VL - 38

SP - 480

EP - 486

JO - Auris Nasus Larynx

JF - Auris Nasus Larynx

SN - 0385-8146

IS - 4

ER -